Lisinopril vs losartan efficacy
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril vs Losartan Efficacy in Cardiovascular and Renal Conditions
Efficacy in Cardiomyopathy and Heart Disease
In boys with Duchenne muscular dystrophy and newly diagnosed cardiomyopathy, both lisinopril (an ACE inhibitor) and losartan (an angiotensin receptor blocker) led to significant and similar improvements in heart function, as measured by ejection fraction over one year. There was no difference in therapeutic effect between the two drugs for this specific condition .
For patients with hypertension and left ventricular hypertrophy, lisinopril improved myocardial perfusion reserve and maximal coronary blood flow, while losartan did not show such improvements. This suggests that lisinopril may be more effective than losartan in repairing coronary microangiopathy in hypertensive heart disease .
Blood Pressure and Pulse Pressure Control
In hypertensive patients, lisinopril was found to be more effective than losartan in reducing both blood pressure and pulse pressure, especially when measured at home or with ambulatory monitoring. The difference was less clear when measured in a clinical setting, but overall, lisinopril showed greater antihypertensive effects .
A large real-world study comparing once-daily and twice-daily dosing of both drugs found no significant difference in blood pressure control between the two dosing regimens for either lisinopril or losartan. This suggests that increasing dosing frequency does not improve efficacy for either medication .
Renal Protection and Proteinuria
Both lisinopril and losartan significantly reduced microalbuminuria in patients with type 2 diabetes, with no statistically significant difference in efficacy between the two drugs . In children with mild IgA nephropathy, lisinopril monotherapy was as effective as combination therapy with lisinopril and losartan in reducing proteinuria, with similar safety profiles .
In patients with significant proteinuria and kidney disease, high-dose lisinopril reduced proteinuria more than losartan, and combination therapy (lisinopril plus losartan) was even more effective. However, increasing the dose of losartan alone was better tolerated than combination therapy, though the combination had a slight edge in patients with very high proteinuria 89.
Metabolic Effects
Lisinopril improved insulin sensitivity in non-diabetic hypertensive patients, while losartan did not have a significant effect on insulin sensitivity. This difference may be relevant for patients at risk of developing diabetes or with metabolic concerns .
Safety and Side Effects
Lisinopril is associated with a higher incidence of dry cough compared to losartan. In patients with a history of ACE inhibitor-induced cough, losartan had a similar incidence of cough as placebo, making it a better option for those who experience this side effect with lisinopril . Both drugs were otherwise well tolerated in the studies reviewed.
Conclusion
Lisinopril and losartan are both effective for treating hypertension, reducing proteinuria, and managing certain heart and kidney conditions. Lisinopril may offer advantages in improving heart blood flow and insulin sensitivity, but is more likely to cause cough. Losartan is equally effective in many settings and is better tolerated in patients prone to cough. For most patients, the choice between these medications can be guided by individual risk factors, side effect profiles, and specific clinical needs 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic